We are live on
!
Find out more
YIH
Y-Intercept (HK) Portfolio holdings
AUM
$5.05B
1-Year Est. Return
17.89%
This Fund
S&P 500
This Quarter
Est. Return
+8.14%
1 Year Est. Return
+17.89%
3 Year Est. Return
+34.37%
5 Year Est. Return
+20.59%
10 Year Est. Return
–
AUM
$4.09B
AUM Growth
+$2.61B
(+177%)
Cap. Flow
+$2.46B
Cap. Flow
% of AUM
60.1%
Top 10 Holdings %
Top 10 Hldgs %
6.33%
Holding
2,105
New
963
Increased
487
Reduced
137
Closed
518
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$37.8M |
| 2 |
Sarepta Therapeutics
SRPT
|
+$35.1M |
| 3 |
T-Mobile US
TMUS
|
+$30.4M |
| 4 |
Nu Holdings
NU
|
+$27.8M |
| 5 |
Consolidated Edison
ED
|
+$26.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Arista Networks
ANET
|
+$17M |
| 2 |
Marvell Technology
MRVL
|
+$16.2M |
| 3 |
NVO
Novo Nordisk
NVO
|
+$16.1M |
| 4 |
ServiceNow
NOW
|
+$13.3M |
| 5 |
Walmart Inc
WMT
|
+$10.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.87% |
| 2 | Industrials | 14.69% |
| 3 | Financials | 14.36% |
| 4 | Healthcare | 12.68% |
| 5 | Consumer Discretionary | 12.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EXAS
326
DELISTED
Exact Sciences
EXAS
| $3.72M | 0.09% |
+69,932
| New | +$3.55M |
|
327
Meritage Homes
MTH
$4.82B
| $3.71M | 0.09% |
+55,450
| New | +$3.67M |
|
328
Corning
GLW
$108B
| $3.71M | 0.09% |
70,589
+22,450
| +47% | +$1.05M |
|
329
Plexus
PLXS
$6.23B
| $3.71M | 0.09% |
27,415
+24,492
| +838% | +$3.14M |
|
330
Asana
ASAN
$1.96B
| $3.71M | 0.09% |
274,702
+220,079
| +403% | +$3.45M |
|
331
ScottsMiracle-Gro
SMG
$4.03B
| $3.7M | 0.09% |
56,144
+47,463
| +547% | +$2.74M |
|
332
SoundHound AI
SOUN
$2.54B
| $3.7M | 0.09% |
+344,423
| New | +$3.24M |
|
333
Americold
COLD
$4.19B
| $3.69M | 0.09% |
221,879
+187,448
| +544% | +$3.4M |
|
334
Fidelity National Financial
FNF
$14.6B
| $3.68M | 0.09% |
+65,705
| New | +$3.84M |
|
335
Valvoline
VVV
$5.05B
| $3.67M | 0.09% |
96,839
+71,851
| +288% | +$2.51M |
|
336
Patterson-UTI
PTEN
$3.57B
| $3.66M | 0.09% |
+617,908
| New | +$3.72M |
|
337
Zillow
Z
$7.82B
| $3.66M | 0.09% |
52,235
+32,442
| +164% | +$2.19M |
|
338
monday.com
MNDY
$3.83B
| $3.65M | 0.09% |
11,603
+1,565
| +16% | +$436K |
|
339
Revolution Medicines
RVMD
$38.2B
| $3.64M | 0.09% |
+98,904
| New | +$3.8M |
|
340
Matsons
MATX
$6.05B
| $3.64M | 0.09% |
32,671
+29,057
| +804% | +$3.18M |
|
341
Yelp
YELP
$1.53B
| $3.63M | 0.09% |
+106,010
| New | +$3.83M |
|
342
Invesco
IVZ
$12.5B
| $3.63M | 0.09% |
230,252
+138,752
| +152% | +$1.99M |
|
343
PennyMac Financial
PFSI
$4.46B
| $3.62M | 0.09% |
36,348
+29,408
| +424% | +$2.85M |
|
344
Nike
NKE
$63.2B
| $3.62M | 0.09% |
+50,954
| New | +$3.06M |
|
345
DigitalBridge
DBRG
$2.93B
| $3.62M | 0.09% |
+349,442
| New | +$3.33M |
|
346
World Kinect Corp
WKC
$2.05B
| $3.61M | 0.09% |
+127,502
| New | +$3.38M |
|
347
Enovix
ENVX
$840M
| $3.61M | 0.09% |
+399,258
| New | +$2.6M |
|
348
Harmony Gold Mining
HMY
$9.58B
| $3.61M | 0.09% |
+258,352
| New | +$3.91M |
|
349
Flutter Entertainment
FLUT
$19B
| $3.6M | 0.09% |
12,608
+6,878
| +120% | +$1.69M |
|
350
Zimmer Biomet
ZBH
$18.6B
| $3.6M | 0.09% |
+39,469
| New | +$3.82M |
|
Similar funds
HSA
O
LFG
JIM
CTC
NL
BPWM
VT
Y-Intercept (HK)'s Q2 2025 Portfolio in Review
As of Q2 2025, Y-Intercept (HK) held 2,105 positions worth $4.09B, up 177% from $1.48B the previous quarter. Its ten largest holdings account for 6.3% of the portfolio.
Y-Intercept (HK) deployed $2.46B of net new capital in Q2 2025, opening 963 new positions and adding to 487 existing holdings. Its largest new stake was Nu Holdings: 2,319,643 shares worth $31.8M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 19% a quarter earlier, followed by Industrials and Financials.
On the sell side, the largest reduction was Novo Nordisk, an estimated $16.1M trimmed.
- Y-Intercept (HK)'s largest Q2 2025 buy was Nu Holdings: 2,319,643 shares worth $31.8M.
- Y-Intercept (HK) added most to UnitedHealth in Q2 2025, an estimated $37.8M increase.
- Y-Intercept (HK)'s biggest Q2 2025 reduction was Novo Nordisk, cutting an estimated $16.1M.
- Y-Intercept (HK) fully exited Arista Networks in Q2 2025, selling an estimated $17M.
- Y-Intercept (HK)'s ten largest holdings make up 6.3% of its $4.09B portfolio in Q2 2025.
- Y-Intercept (HK) opened 963 new positions and closed 518 in Q2 2025.
- Y-Intercept (HK)'s portfolio value rose 177% quarter-over-quarter to $4.09B.
Based on Y-Intercept (HK)'s 13F filing for Q2 2025, filed 1 Aug 2025.